JP Patent

JP2008515910A6 — 薬物の塩およびその結晶形

Assigned to Abbott Laboratories · Expires 2016-10-06 · 10y expired

What this patent protects

薬物の結晶形、その製造方法、それを含有する組成物、およびそれを用いる疾患の治療方法および有害生理事象の抑制方法が開示される。

USPTO Abstract

薬物の結晶形、その製造方法、それを含有する組成物、およびそれを用いる疾患の治療方法および有害生理事象の抑制方法が開示される。

Drugs covered by this patent

delafloxacin-meglumine (DELAFLOXACIN MEGLUMINE)

Patent Metadata

Patent number: JP2008515910A6
Jurisdiction: JP
Classification: —
Expires: 2016-10-06
Drug substance claim: No
Drug product claim: No
Assignee: Abbott Laboratories
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.